Surgical treatment for breast cancer in a patient with erythropoietic protoporphyria and photosensitivity: a case report

por Shimazaki, Akiko, Hashimoto, Takuma, Kai, Masaya, Nakayama, Tetsuzo, Yamada, Mai, Zaguirre, Karen, Tokuda, Kentaro, Kubo, Makoto, Yamaura, Ken, Nakamura, Masafumi
Publicado 2021

Genetic medicine is accelerating in Japan

por Hayashi, Saori, Kubo, Makoto, Kaneshiro, Kazuhisa, Kai, Masaya, Yamada, Mai, Morisaki, Takafumi, Takao, Yuka, Shimazaki, Akiko, Shikada, Sawako, Nakamura, Masafumi
Publicado 2022

A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome

por Kai, Masaya, Kubo, Makoto, Shikada, Sawako, Hayashi, Saori, Morisaki, Takafumi, Yamada, Mai, Takao, Yuka, Shimazaki, Akiko, Harada, Yurina, Kaneshiro, Kazuhisa, Mizuuchi, Yusuke, Shindo, Koji, Nakamura, Masafumi
Publicado 2022

Granzyme B Expression in the Tumor Microenvironment as a Prognostic Biomarker for Patients with Triple-Negative Breast Cancer

por Mizoguchi, Kimihisa, Kawaji, Hitomi, Kai, Masaya, Morisaki, Takafumi, Hayashi, Saori, Takao, Yuka, Yamada, Mai, Shimazaki, Akiko, Osako, Tomofumi, Arima, Nobuyuki, Okido, Masayuki, Oda, Yoshinao, Nakamura, Masafumi, Kubo, Makoto
Publicado 2023

Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients

por Zaguirre, Karen, Kai, Masaya, Kubo, Makoto, Yamada, Mai, Kurata, Kanako, Kawaji, Hitomi, Kaneshiro, Kazuhisa, Harada, Yurina, Hayashi, Saori, Shimazaki, Akiko, Morisaki, Takafumi, Mori, Hitomi, Oda, Yoshinao, Chen, Sanmei, Moriyama, Taiki, Shimizu, Shuji, Nakamura, Masafumi
Publicado 2021

Comprehensive molecular profiling broadens treatment options for breast cancer patients

por Kawaji, Hitomi, Kubo, Makoto, Yamashita, Nami, Yamamoto, Hidetaka, Kai, Masaya, Kajihara, Atsuko, Yamada, Mai, Kurata, Kanako, Kaneshiro, Kazuhisa, Harada, Yurina, Hayashi, Saori, Shimazaki, Akiko, Mori, Hitomi, Akiyoshi, Sayuri, Oki, Eiji, Oda, Yoshinao, Baba, Eishi, Mori, Masaki, Nakamura, Masafumi
Publicado 2020